Anzeige
Mehr »
Dienstag, 01.07.2025 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DJ5B | ISIN: IE00BDGMC594 | Ticker-Symbol: AWK
Tradegate
30.06.25 | 18:22
7,600 Euro
+0,66 % +0,050
Branche
Pharma
Aktienmarkt
NASDAQ Biotech
1-Jahres-Chart
AVADEL PHARMACEUTICALS PLC Chart 1 Jahr
5-Tage-Chart
AVADEL PHARMACEUTICALS PLC 5-Tage-Chart
RealtimeGeldBriefZeit
7,4507,60009:03
7,4507,60009:02

Aktuelle News zur AVADEL PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoAvadel stock rises after appeals court upholds LUMRYZ approval3
MoInvestor urges Avadel shareholders to vote against directors2
MoAvadel Pharmaceuticals plc: Avadel Pharmaceuticals Announces Unanimous Appeals Court Decision Upholding FDA Approval of LUMRYZ in Narcolepsy in Administrative Procedure Act Litigation70DUBLIN, June 30, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced that, on Friday, June...
► Artikel lesen
MoAvadel Pharmaceuticals steht vor Vorstandsherausforderung durch Investor ASL Strategic Value1
MoAvadel Pharmaceuticals faces board challenge from investor ASL Strategic Value - report1
AVADEL PHARMACEUTICALS Aktie jetzt für 0€ handeln
FrAVADEL PHARMACEUTICALS PLC - 8-K, Current Report2
16.06.Avadel Pharmaceuticals plc: Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)48DUBLIN, June 16, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee...
► Artikel lesen
05.06.Avadel Pharmaceuticals auf Jefferies-Konferenz: Strategisches Wachstum und Herausforderungen1
05.06.Avadel gets FDA's Orphan Drug status for sleep disorder treatment3
05.06.Avadel Pharma Says FDA Grants Orphan Drug Designation For LUMRYZ To Treat Idiopathic Hypersomnia1
05.06.FDA grants orphan drug status to Avadel's IH treatment3
05.06.Avadel Pharmaceuticals plc: Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia76DUBLIN, June 05, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that LUMRYZTM...
► Artikel lesen
05.06.AVADEL PHARMACEUTICALS PLC - 8-K, Current Report-
13.05.Avadel Pharmaceuticals appoints Susan Rodriguez as COO2
13.05.Avadel appoints new COO to boost narcolepsy drug growth3
13.05.AVADEL PHARMACEUTICALS PLC - 8-K, Current Report1
13.05.Avadel Pharmaceuticals plc: Avadel Pharmaceuticals Expands Leadership Team with Appointment of Susan Rodriguez as Chief Operating Officer175DUBLIN, May 13, 2025 (GLOBE NEWSWIRE) -- DUBLIN, May 13, 2025 - Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, today announced...
► Artikel lesen
08.05.Avadel Pharmaceuticals plc: Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)92DUBLIN, May 08, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee...
► Artikel lesen
07.05.AVADEL PHARMACEUTICALS PLC - 10-Q, Quarterly Report-
07.05.Avadel Pharmaceuticals GAAP EPS of -$0.051
Weiter >>
55 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1